The mechanisms by which cationic amino acids influence pancreatic B-cell function have been studied by monitoring simultaneously 86Rb+ efflux and insulin release from perifused rat islets. The effects of two reference amino acids arginine and lysine were compared with those of closely related substances to define the structural requirements for recognition of these molecules as secretagogues. Arginine accelerated 86Rb+ efflux and increased insulin release in the absence or in the presence of 7mM-glucose. Its effects on efflux did not require the presence of extracellular Ca2+ or Na+, but its insulinotropic effects were suppressed in a Ca2+-free medium and inhibited in an Na+-free medium. Among arginine derivatives, only 2-amino-3-guanidinopropionic acid mimicked its effects on 86Rb+ efflux and insulin release; citrulline, guanidinoacetic acid, 3-guanidinopropionic acid and guanidine were inactive. Norvaline and valine also increased 86Rb+ efflux, but their effect required the presence of extracellular Na+; they did not stimulate insulin release. Lysine as well as the shorter-chain cationic amino acids ornithine and 2,4-diaminobutyric acid accelerated 86Rb+ efflux in a Ca2+-and Na+-independent manner. Their stimulation of insulin release was suppressed by Ca2+ omission, but only partially inhibited in an Na+-free medium. The uncharged glutamine and norleucine increased the rate of 86Rb+ effiux in the presence of glucose, only if extracellular Na+ was present. Norleucine slightly increased release in a Ca2+-and Na+-dependent manner. The effects of lysine on efflux and release were not mimicked by other related substances such as 1,5-diaminopentane and 6-aminohexanoic acid. The results suggest that the depolarizing effect of cationic amino acids is due to accumulation of these positively charged molecules in B-cells. This causes acceleration of the efflux of K+ (86Rb+) and activation of the influx of Ca2+ (which triggers insulin release). The prerequisite for the stimulation of B-cells by this mechanism appears to be the presence of a positive charge on the side chain of the amino acid, rather than a specific group.
The ability of amino acids to stimulate insulin secretion was first recognized by studies in vivo (Floyd et al., 1963) . Despite numerous investigations (see Panten, 1975) on the transport, degradation and metabolic effects of amino acids in islet cells, the mechanisms by which they trigger insulin release are only now being unravelled.
It has been speculated that leucine and arginine, the most frequently studied amino acids, act on pancreatic B-cells by different mechanisms (Fajans et al., 1972) . This suggestion was mainly based on the observation that leucine-but not arginine-* Deceased 9 March, 1982. t To whom reprint requests should be sent.
induced insulin release in man is inhibited by diazoxide (Fajans et al., 1967) . From the characteristics of the release of insulin, it has also been inferred that the actions of arginine and glucose on B-cells are not only quantitatively, but also qualitatively, different (Fajans et al., 1972; Levin et al., 1972; Gerich et al., 1974) . For many years, however, the experimental evidence supporting these proposals has remained very limited. It was only known that, in contrast with glucose and leucine, arginine is practically not metabolized (Hellman et al., 197 la) and does not increase the level of reduced nicotinamide nucleotides (Panten & Christians, 1973 ; Panten, 1975) Recent studies strongly suggest that the metabolic degradation of leucine by pancreatic B-cells is an integral part of stimulus-secretion coupling (Malaisse et al., 1980) . The evidence that acceleration of metabolic fluxes in islet cells also plays a central role in the insulinotropic effects of 4-methyl-2-oxopentanoate (a metabolite of leucine) and 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (a non-metabolizable analogue of leucine) has been reviewed recently (Ashcroft, 1981; Malaisse et al., 1981) . In addition, leucine and its derivatives share with glucose the ability to depolarize the B-cell membrane by decreasing its permeability to K+ and they induce an electrical activity similar to that produced by the sugar (Henquin & Meissner, 1981) . By contrast, arginine increases the K+ permeability of the B-cell membrane and its depolarizing effect has tentatively been ascribed to accumulation of that positively charged molecule in B-cells (Henquin & Meissner, 1981) .
The present investigation, partially reported in abstract form (Charles et al., 1981) , is a 'structurefunction' study of cationic amino acids. Its objective was to determine whether a single mode of action underlies the effects of structurally different cationic amino acids on pancreatic B-cells. We simultaneously monitored 86Rb+ efflux and insulin release from perifused rat islets to establish whether there exists a link between the ability of these amino acids to change the K+ permeability of the B-cell membrane (Henquin, 1980b) and to activate the releasing process. We further compared the effects of the reference amino acids arginine and lysine to those of closely related substances to define the structural requirements for recognition of these molecules as insulin secretagogues.
Materials and methods
All experiments were made with islets isolated by collagenase digestion of the pancreas of fed male Wistar rats and incubated or perifused in a bicarbonate-buffered medium (Henquin, 1980a) . When CaCl2 was omitted from the medium, the concentration of NaCl was increased to maintain iso-osmolarity and the total Ca2+ concentration, measured by atomic-absorption spectroscopy, was less than 30pM. Na+-free solutions were prepared by substituting choline chloride and choline bicarbonate for Na+ salts; these solutions were supplemented with lO,uM-atropine to prevent any cholinergic effect of choline. The amino acids studied were added to the medium without correction for osmolarity, but, when necessary, the pH of the medium was adjusted back to 7.4 after addition of the test substance. Stability of the pH was systematically checked at the end of the experiments.
The perifusion system used to monitor the efflux of 86Rb+ from preloaded islets has been described previously (Henquin, 1978 
Results and discussion
Effects on 86Rb+ efflux (a) Arginine and related substances. In the absence of glucose, the rate of 86Rb+ efflux from perifused islets declined slowly and regularly (Fig.  1) . Addition of 20mM-arginine (2-amino-5-guanidinopentanoic acid) to the medium resulted in a rapid increase in the efflux rate. This effect was completely reversible on removal of the amino acid (Fig. la) . A derivative of arginine, lacking two methylene groups (2-amino-3-guanidinopropionic acid), also slightly increased 86Rb+ efflux (Table 1) .
By contrast, substitution of the guanidine group of arginine by a non-ionized ureido group (citrulline; 2-amino-5-ureidopentanoic acid) was sufficient to make the molecule inactive. However, the effect cannot be ascribed to the guanidine group alone, since neither guanidine alone nor guanidinoacetic acid or 3-guanidinopropionic acid, which both lack an ionized a-amino group, increased 86Rb+ efflux (Table 1) . It was expected that the absence of the ionized guanidine group would produce an inactive Table 1 . Effects ofcationic amino acids and related substances on 86Rb+ efflux and insulin releasefrom rat islets After loading with 86Rb+, the islets were perifused in the absence of glucose. After 40 min, test substances were added to the perifusion medium for 20min. For each individual experiment the average fractional rate of 86Rb+ efflux was calculated for the period 40-60min of stimulation with the different test substances. These values are expressed as percentages of the average fractional efflux rate recorded, during the same period, in the absence of test substance. This absolute control value was 0.0243 + 0.0006. The increase or decrease in insulin release (A) produced by the test substance was calculated as the total release during the test period (40-60min), above or below a constant rate of secretion evaluated from the last 6min (34-40min) of the preceding control period. The total amount of insulin secreted by control islets during the reference period was 190 ± 18 pg/islet per 20 min. Results are means + S.E.M. of n experiments. Significance levels: *P < 0.05; **P < 0.005; ***P < 0. neutral molecule. Surprisingly, norvaline (2-aminopentanoic acid) and its branched analogue valine accelerated 86Rb+ efflux (Figs. lb and ic) . Removal of norvaline, but not of valine, was paradoxically followed by a large rise in the rate of 86Rb+ efflux (Fig. Ib) .
In the presence of 7 mM-glucose, the rate of 86Rb+ efflux was lower and more stable, at least in the control medium. In the absence of extracellular Ca2+, the stability was less good and, in the absence of extracellular Na+, the rate of efflux continued to decrease slightly during the whole experiment (Fig.  2) . Addition of arginine (10mM) was followed by a rapid, marked and reversible increase in the efflux rate. This effect did not require the presence of extracellular Ca2+ or Na+. In the Na+-free medium, the efflux of 86Rb+ fell below control values on removal of arginine (Fig. 2c) . Among arginine Vol. 208 Arginine (0) Lysine ( . Effects ofarginine and lysine on 86Rb+ efflux and insulin releasefrom perifused islets The experiments were carried out in the presence of 7 mM-glucose. Ca2+ was omitted from the medium in (b) and (b'); Na+ was replaced by choline in (c) and (c'). As indicated, 10mM-arginine (0) or -lysine (0) derivatives, citrulline, guanidine, guanidinoacetic acid and 3-guanidinopropionic acid were without significant effect, whereas 2-amino-3-guanidinopropionic acid slightly increased the efflux rate (Table   2 ). Norvaline and valine again accelerated 86Rb+ efflux; their effect was less marked than that of arginine, did not require extracellular Ca2+ but was suppressed in the absence of Na+ (Table 2) . ,X-V-,::: ... Table 3 . Changes in insulin release produced by cationic amino acids and related substances in rat islets perifused without Na+ and Ca2+ The experiments, carried out in the presence of 7 mM-glucose, are the same as those presented in (b) Lysine and related substances. In the absence of glucose, 20mM-lysine (2,6-diaminohexanoic acid) increased the rate of s6Rb+ efflux from perifused islets (Fig. la ). An even greater increase was observed on addition of ornithine (2,5-diaminopentanoic acid), whereas the uncharged glutamine (2,5-diamino-5-oxopentanoic acid) had no effect (Table 1) . Norleucine (2-aminohexanoic acid), which differs from lysine only in the absence of the NH2 group in position-6, slightly decreased 86Rb+ efflux (Fig. lb) . This decrease was, however, less marked than that produced by the branched amino acid leucine (Fig. lc) . On the other hand, the efflux rate was unaffected by 1,5-diaminopentane (the decarboxylation product of lysine) or by 6-aminohexanoic acid, which lacks the a-amino group of lysine.
In the presence of 7mM-glucose, 10mM-lysine rapidly, markedly and reversibly increased the rate of 86Rb+ efflux. This increase also occurred when Ca2+ or Na+ was omitted from the perifusion medium (Fig. 2) . As previously observed with arginine, removal of lysine from the Na+-free medium was followed by a fall in the efflux rate below control values (Fig. 2c) . A similar Ca2+-and Na+-independent acceleration of 86Rb+ efflux was also produced by ornithine and by an even shorter cationic amino acid, 2,4-diaminobutyric acid (Table   2 ). Although uncharged, glutamine and norleucine brought about a slight increase in the rate of 86Rb+ efflux; this effect persisted in the absence of extracellular Ca2+, but was suppressed by omission of Na+ (Table 2) . On the other hand, 1,5-diaminopentane and 6-aminohexanoic acid decreased 86Rb+ efflux (Table 2) ; withdrawal of the former of these substances was followed by a rebound increase above control values (results not shown).
From all these experiments with arginine and lysine derivatives it appears that the ability to increase 86Rb+ efflux from islet cells is a common property of quite different molecules, which all are cationic amino acids. This property is Na+-and Ca2+-independent, but is suppressed by small alterations of the molecule, which change its ionization state. This strongly suggests that the presence of a positive charge on the side chain, rather than the nature of the group responsible for the charge, is the prerequisite for an increase in the efflux rate. A further test of this hypothesis would be to change the proportion of molecules with an ionized basic group on the side chain. In practice this is not possible, however, because the pK values of these ionizable groups are too far away from the physiological pH. The interpretation of such experiments would also be complicated by the marked effect of extracellular pH on 86Rb+ efflux from islet cells (Henquin, 1981) . Vol. 208 At first glance, this hypothesis may seem inconsistent with the increase in 86Rb+ efflux brought about by the neutral amino acids norvaline, valine, norleucine and glutamine. However, the Na+-dependency of the effect of these substances makes their property clearly distinguishable from that of cationic amino acids. The most plausible explanation is that they are transported in islet cells with Na+ and that this influx of positive charges causes the efflux of K+. In other tissues, glutamine, norvaline and norleucine are transported by the Na+-requiring system A or ASC (Christensen, 1973) . Valine, like leucine, usually prefers the Na+-independent system L, but it should be noted that in islet cells, leucine uptake is partially Na+-dependent (Hellman et al., 197 lb) . This may indicate some participation of the system A for the transport of these branched-chain amino acids (Christensen, 1973) . It is also pertinent to mention that, in the exocrine pancreas, the small depolarization produced by valine has been ascribed to an increase in membrane Na+ conductance (Iwatsuki & Petersen, 1980) . Effects on insulin release (a) Arginine and related substances. The insulinotropic effect of arginine in the absence of glucose has long been controversial (see Gerich et al., 1974; Panten, 1975) . Table 1 shows that in perifused rat islets 20mM-arginine produced a weak but definite stimulation of insulin release. A similar effect was also observed with incubated rat islets (Henquin et al., 1982) . By contrast, none of the arginine derivatives increased insulin release in the absence of the sugar (Table 1) .
In control conditions, 7 mM-glucose steadily stimulated insulin release; this effect was abolished in a Ca2+-free medium and progressively faded out in an Na+-free medium (Fig. 2) . Addition of 10mM-arginine to the normal medium containing 7 mM-glucose triggered a rapid and large increase in insulin release, which stopped after withdrawal of the amino acid. Such a stimulation did not occur in the absence of extracellular Ca2+ and was markedly impaired, though not abolished, in the absence of extracellular Na+ (Figs. 2b' and 2c'; Table 3 ). Only 2-amino-3-guanidinopropionic acid was able to mimic, less powerfully, the releasing effect of arginine. Guanidinoacetic acid, 3-guanidinopropionic acid, guanidine and norvaline had no significant effect. Glucose-induced insulin release was slightly inhibited by valine in the normal medium; this branched-chain amino acid was without effect in the absence of Ca2+ or Na+ (Table 3) .
The molecular requirements for the stimulation of insulin release by arginine have already been evaluated in a few previous studies. It was first reported that guanidine and guanidinoacetic acid were able to increase insulin release in the perfused pancreas and this observation prompted the suggestion that the arginine molecule had to be converted into such products to trigger the releasing process (Alsever et al., 1970 ). An acute -intravenous injection of guanidine to rats increased plasma insulin levels, but this effect was inhibited by atropine (Aynsley-Green & Alberti, 1974) . With isolated rat islets, guanidine proved ineffective in this and in another study (Marco et al., 1976) . The effect of guanidinoacetic acid could not be confirmed in vivo (Aynsley-Green & Alberti, 1974) or in vitro (Alberti & Whalley, 1973) , but the cationic amino acids 2-amino-3-guanidinopropionic acid and 2-amino-4-guanidinobutyric acid increased insulin release in the presence of glucose (Alberti & Whalley, 1973) . In one report norvaline was found to stimulate insulin release, but it proved inactive in this and two other studies (Alberti & Whalley, 1973; Sch6nborn et al., 1975) . Taken together our results and those of Alberti & Whalley (1973) show that the insulinotropic property of arginine is lost if the ionization state of the molecule is altered by removing one of its basic groups.
(b) Lysine and related substances. In a glucosefree medium, 20 mM-lysine stimulated insulin release. Among its derivatives, only ornithine exerted a similar effect (Table 1) .
In the presence of 7mM-glucose, 10mM-lysine triggered a marked and reversible increase in insulin release. This effect was abolished in the absence of extracellular Ca2+, but not totally suppressed by omission of Na+ (Fig. 2) . Insulin release was also augmented by the two other cationic amino acids, ornithine and 2,4-diaminobutyric acid; this increase had an absolute requirement for extracellular Ca2+, but was only partially inhibited in the absence of Na+ (Table 3 ). In agreement with the results of a recent study using incubated rat islets , glutamine was without effect and norleucine increased insulin release (Table 3) . Interestingly, the effect of norleucine was much weaker than that of related cationic amino acids and was completely suppressed in the absence of Na+. 1,5-Diaminopentane did not alter glucose-induced release, but its withdrawal from the perifusion medium was accompanied by an unexplained increase in secretion (results not shown). For an unknown reason, 6-aminohexanoic acid partially and reversibly inhibited insulin release induced by 7mM-glucose (Table 3 ).
The complete suppression of the insulinotropic effect of all these cationic amino acids by omission of extracellular Ca2+ suggests that an influx of Ca2+ is involved in the stimulus-secretion coupling. This is in complete agreement with the blockade by compound D600 of arginine-or lysine-stimulated insulin release and Ca2+ uptake (Henquin et al., 1982) . By contrast, cationic amino acids remained able to increase release in the absence of Na+, whereas the insulinotropic effect of glucose itself was diminishing. It is not clear whether their reduced effectiveness in the Na+-free medium is merely due to suppression of the potentiating effect of glucose, the metabolism of which is impaired in the absence of extracellular Na+ (Hellman et al., 1974 ), or to another mechanism. Additional studies are necessary to answer that question.
General discussion and conclusions
The ability of cationic amino acids to trigger an efflux of K+ (86Rb+) is not restricted to islet cells. Their accumulation in muscle cells is also accompanied by a loss of cellular K+ (Levinsky et al., 1962; Arnauld & Lachance, 1980) , which likely accounts for the rise in plasma [K+ I that can be measured during intravenous infusion of arginine (Dicherman & Walker, 1964; Massara et al., 1979) . A similar efflux of K+ also takes place during uptake of cationic amino acids by plant cells (Komor et al., 1981) .
Previous studies (Hellman et al., 197 lb; Christensen et al., 1971; Cooperstein & Lazarow, 1977) have shown that mouse or toadfish islet cells markedly accumulate arginine, lysine and 4-amino-1-guanylpiperidine-4-carboxylic acid, a nonmetabolizable analogue for the transport system of cationic amino acids. It thus seems reasonable to admit that pancreatic B-cells are equipped with such a system and that it is most likely Na+-independent as in other tissues (Heinz, 1972; Christensen, 1973) .
The present study strongly suggests that the different cationic amino acids can be viewed as a single family of substances that stimulate B-cells by a single simple mechanism. The accumulation of these positively charged molecules in B-cells appears to be an electrogenic process; thus, arginine depolarizes the plasma membrane of mouse B-cells (Henquin & Meissner, 1981) and a similar effect has been observed recently with lysine and ornithine (J. C. Henquin & H. P. Meissner, unpublished work). The depolarization may, in turn, activate voltagedependent Ca2+-channels and the ensuing Ca2+ influx trigger insulin release (hence the suppression of release in the absence of Ca2+). Simultaneously, the depolarization causes an efflux of K+ (s6Rb+) through voltage-dependent K+-channels, an effect that does not require the presence of Ca2+ to occur. The prerequisite to trigger these events is thus the presence of a positive charge on the side chain rather than a specific group.
The major characteristic of the stimulus-secretion coupling for these cationic amino acids is that, contrary to glucose or leucine and their analogues, it does not involve a decrease in the K+ permeability of the B-cell membrane. As diazoxide inhibits B-cell function by increasing the K+ permeability of its plasma membrane (Henquin et al., 1982) , it is easy to understand why leucine-but not argininestimulated insulin release is inhibited by the drug, as originally observed in vivo (Fajans et al., 1967) and recently confirmed in vitro (Henquin et al., 1982) . Finally, the simple mode of action proposed here for these cationic amino acids may account for their depolarizing effect in other tissues like the exocrine pancreas (Laugier & Petersen, 1981) . It may explain their stimulation of glucagon release (Assan et al., 1977) and of the secretory function of other gland cells equipped with voltage-dependent Ca2+-channels.
